Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint

<p>Leukemia, Published online: 18 November 2025; <a href="https://www.nature.com/articles/s41375-025-02796-z">doi:10.1038/s41375-025-02796-z</a></p>Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint